Rare Disease Registry for Movement Disorders in Southern Anhui
Official title: Rare Disease Registry Database for Movement Disorders in Southern Anhui Province
Run by First Affiliated Hospital of Wannan Medical College · NCT07838883 · Data updated 2026-11-12
This project is creating a registry to collect information from adults with motor neuron diseases, spinocerebellar ataxias, hereditary muscular dystrophy, or hereditary spastic paraplegia in Southern Anhui.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | First Affiliated Hospital of Wannan Medical College Academic / other |
| Locations | 1 site (Wuhu, Anhui) |
| Status | Recruiting |
| Started | September 30, 2026 |
| Main results expected | September 2029 |
| Study ends | September 2029 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07838883 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 19 years or older with a definitive diagnosis of ALS/MND, spinocerebellar ataxia, muscular dystrophy, or hereditary spastic paraplegia who can provide informed consent.
✕Probably not a fit
Patients who cannot provide informed consent or lack a definite diagnosis may not benefit directly from the registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry aims to document clinical features, diagnoses, and outcomes in patients with selected motor neuron and hereditary movement disorders. It collects data from eligible adults at a single center in Wuhu, Anhui, to better understand these rare conditions. The study addresses challenges in rare disease research such as small patient numbers and symptom diversity by systematically compiling patient information for future analyses. It does not involve an experimental treatment but focuses on data collection to support improved care and research planning. Participation is based on informed consent and specific diagnostic criteria.
Why it matters
Potential benefit: Participants may contribute to a better understanding of their condition and help build knowledge that could improve future diagnosis and care.
How similar studies have gone: Other rare-disease registries have shown value in improving understanding and guiding research, though specific outcomes vary by condition.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 19 years or older who are capable of giving informed consent. * Definitive diagnosis of one of the following diseases: (1) amyotrophic lateral sclerosis (diagnosed according to the revised El Escorial criteria, Awaji criteria, or Gold Coast criteria); (2) spinocerebellar ataxia; (3) muscular dystrophy; (4) hereditary spastic paraplegia. * Others: primary lateral sclerosis, progressive muscular atrophy, ALS-FTD syndrome, progressive bulbar palsy, benign focal muscular atrophy, and other motor neuron diseases. Exclusion Criteria: * Patients with concomitant systemic diseases; * Vulnerable research subjects: minors and patients with cognitive impairment; * Participants from whom clinical information and human biological samples cannot be collected; * Other patients judged by the investigators to be unsuitable for participation in the study.
Where it's running
-
First affiliated hospital of Wannan Medical University
Wuhu, Anhui, China Recruiting
Study contacts
- Study coordinator: Xianjin Shang, Prof.
- Email: shangxj2013@wnmc.edu.cn
- Phone: 86 151 5530 0503
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TreatHSP/SPAX: An adaptive natural history platform for SPAX diseases
This study tests a shared, long-term framework to track how SPAX diseases progress and to develop useful patient-centered outcome measures and biomarkers.
-
Noninvasive spinal stimulation to improve walking in hereditary spastic paraplegia
This trial will test whether noninvasive transcutaneous spinal cord stimulation can improve walking and reduce muscle stiffness in adults with hereditary spastic paraplegia.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
Evaluating surgical treatment for foot deformities in hereditary spastic paraplegia
This study is testing how well surgery can help people with hereditary spastic paraplegia and foot deformities feel and function better over two years.
-
Exploring intrathecal baclofen treatment for hereditary spastic paraplegia
This study is testing if a special pump that delivers baclofen directly into the spine can help people with hereditary spastic paraplegia improve their movement and quality of life better than taking the medication by mouth.
-
Robot-assisted walking treatment for hereditary spastic paraplegia
This study is testing whether using a robot to help with walking, along with regular physical therapy, can improve movement and quality of life for people with hereditary spastic paraplegia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.